Physician profile
Richard Strathmann
NPI 1356547160
$1,911.96
in general payments reported to CMS, 2019-2025
21 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $253 · 2021: $417 · 2022: $312 · 2023: $246 · 2024: $296 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $336.79 | 2020-2022 | |
| Baxter Healthcare | $277.86 | 2024-2025 | Adept, Seprafilm, Perclot |
| Exeltis, USA INC. | $223.45 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $166.26 | 2022-2025 | |
| Abbvie INC. | $166.24 | 2020-2022 | |
| Pfizer INC. | $148.71 | 2021-2025 | |
| Intuitive Surgical, INC. | $81.58 | 2023 | Da Vinci Surgical System |
| Organon LLC | $78.26 | 2022-2024 | |
| Evofem Biosciences, INC. | $77.90 | 2021-2022 | |
| Hologic Sales and Service, LLC | $58.19 | 2019-2024 | Acessa Provu System |
| Mylan Pharmaceuticals INC. | $51.59 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $45.30 | 2019 | |
| Agile Therapeutics, INC. | $39.13 | 2021 | |
| Merck Sharp & Dohme LLC | $25.74 | 2024 | Gardasil, Gardasil 9 |
| Duchesnay USA Incorporated | $23.19 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $22.86 | 2023 | Seglentis |
| Novo Nordisk INC | $21.48 | 2023 | Wegovy |
| Amgen INC. | $20.66 | 2024 | Evenity, Prolia |
| Myovant Sciences INC. | $18.14 | 2022 | |
| Shield Therapeutics INC | $14.41 | 2023 | Accrufer |
| Allergan, INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Strathmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.